Health Care [ 4/12 ] | Biotechnology [ 13/75 ]
NASDAQ | Common Stock
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer.
The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development.
In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring.
The company was incorporated in 2015 and is headquartered in Menlo Park, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 19, 26 | -2.44 Increased by +15.57% | -2.53 Increased by +3.56% |
| Nov 12, 25 | -2.46 Increased by +29.71% | -3.26 Increased by +24.54% |
| Aug 12, 25 | -3.18 Increased by +93.77% | -3.56 Increased by +10.67% |
| May 13, 25 | -3.10 | -3.99 Increased by +22.31% |
| Feb 20, 25 | -2.89 | -4.97 Increased by +41.85% |
| Nov 12, 24 | -3.50 | -6.43 Increased by +45.57% |
| Aug 13, 24 | -51.06 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 43.60 M Increased by +13.97% | -99.18 M Decreased by -2.17% | Decreased by -227.48% Increased by +10.35% |
| Sep 30, 25 | 36.19 M Increased by +26.32% | -88.98 M Increased by +29.21% | Decreased by -245.83% Increased by +43.96% |
| Jun 30, 25 | 35.54 M Increased by +11.18% | -113.98 M Increased by +92.81% | Decreased by -320.69% Increased by +93.53% |
| Mar 31, 25 | 31.84 M Increased by +19.15% | -106.21 M Increased by +51.48% | Decreased by -333.61% Increased by +59.28% |
| Dec 31, 24 | 38.25 M Increased by +26.14% | -97.07 M Decreased by -1.67 K% | Decreased by -253.75% Decreased by -1.30 K% |
| Sep 30, 24 | 28.65 M Increased by +38.27% | -125.69 M Increased by +85.90% | Decreased by -438.67% Increased by +89.80% |
| Jun 30, 24 | 31.97 M Increased by +42.63% | -1.59 B Decreased by -721.23% | Decreased by -4.96 K% Decreased by -475.76% |
| Mar 31, 24 | 26.72 M Increased by +36.03% | -218.91 M Decreased by -13.04% | Decreased by -819.26% Increased by +16.90% |